The authorization means that the drug can be used by hospitalized patients with suspected or laboratory-confirmed cases of COVID-19 outside of clinical trials or on a compassionate use basis
The Food and Drug Administration on Friday granted an emergency use authorization to Gilead Sciences Inc.’s remdesivir, a decade-old experimental therapy first tested on Ebola disease patients, as a COVID-19 treatment.
Read: Gilead expects to spend up to $1 billion on coronavirus drug this year, will donate 1.5 million vials There’s also an economic angle. The market has been swinging in response to remdesivir data, driven by the investor stance that a proven treatment, even more so than vaccine, would support the prospect of an economic rebound for the U.S., which is thought to be headed for a recession due to the COVID-19 pandemic.
“Remdesivir is an efficacious drug beyond recovery time ,” Dr. Eric Topol, director of the Scripps Research Translational Institute, tweeted this week
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Authorizes Emergency Use of Gilead Drug Remdesivir for Covid-19 PatientsThe Food and Drug Administration’s move came after researchers reported that the Gilead drug shortened the recovery times in people who have fallen ill from the new coronavirus.
Read more »
U.S. FDA moving with 'lightning speed' on Gilead's COVID-19 drug: BloombergThe U.S. Food and Drug Administration is working at 'lightning speed' to review data on Gilead Sciences Inc's experimental antiviral drug remdesivir in treating COVID-19 disease, the head of the agency told Bloomberg in an interview.
Read more »
FDA clears remdesivir for emergency use in treating severely ill COVID-19 patientsBREAKING: FDA authorizes emergency use of remdesivir to treat the most severely ill coronavirus patients.
Read more »
FDA authorizes remdesivir drug as emergency treatment for COVID-19The U.S. Food and Drug Administration (FDA) has granted authorization to Gilead Sciences Inc for emergency use of its experimental antiviral drug remdesivir to treat patients with COVID-19, it said in a letter to Gilead.
Read more »
FDA Has Approved Emergency Use Of Remdesivir To Treat COVID-19The approval comes days after the NIH announcement of preliminary results showing a four-day shortening of hospital stays after treatment with the drug.
Read more »
FDA reportedly will approve Covid-19 treatment remdesivir, which US-funded trial shows has 'positive effect' on recovery timeNew data from a preliminary trial suggests that the drug remdesivir has a positive effect on coronavirus recovery. 'Everything that we've seen so far gives a lot of optimism and hope,' says Dr. Babafemi Taiwo, who is leading part of the study on the drug.
Read more »